288 related articles for article (PubMed ID: 23189181)
21. Ultrasound Modulates Fluorescence Strength and ABCG2 mRNA Response to Aminolevulinic Acid in Glioma Cells.
Higuchi T; Yamaguchi F; Asakura T; Yoshida D; Oishi Y; Morita A
J Nippon Med Sch; 2021 Jan; 87(6):310-317. PubMed ID: 32238732
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels.
Zhou S; Zong Y; Ney PA; Nair G; Stewart CF; Sorrentino BP
Blood; 2005 Mar; 105(6):2571-6. PubMed ID: 15546952
[TBL] [Abstract][Full Text] [Related]
23. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
Howley R; Olsen J; Chen B
Photochem Photobiol; 2024 Mar; ():. PubMed ID: 38477138
[TBL] [Abstract][Full Text] [Related]
25. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
26. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
28. Regulation of 5-aminolevulinic acid-dependent protoporphyrin IX accumulations in human histiocytic lymphoma U937 cells.
Okimura Y; Fujita H; Ogino T; Inoue K; Shuin T; Yano H; Yasuda T; Inoue M; Utsumi K; Sasaki J
Physiol Chem Phys Med NMR; 2007; 39(1):69-82. PubMed ID: 18613640
[TBL] [Abstract][Full Text] [Related]
29. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
30. Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes.
Lin YH; Chang HM; Chang FP; Shen CR; Liu CL; Mao WY; Lin CC; Lee HS; Shen CN
FEBS Lett; 2013 Oct; 587(19):3202-9. PubMed ID: 23954234
[TBL] [Abstract][Full Text] [Related]
31. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Robey RW; Steadman K; Polgar O; Bates SE
Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract][Full Text] [Related]
33. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.
Kitajima Y; Ishii T; Kohda T; Ishizuka M; Yamazaki K; Nishimura Y; Tanaka T; Dan S; Nakajima M
Sci Rep; 2019 Jun; 9(1):8666. PubMed ID: 31209282
[TBL] [Abstract][Full Text] [Related]
35. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
37. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
38. The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.
Kurokawa H; Ito H; Matsui H
Cells; 2019 Aug; 8(8):. PubMed ID: 31426474
[TBL] [Abstract][Full Text] [Related]
39. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.
Chelakkot VS; Liu K; Yoshioka E; Saha S; Xu D; Licursi M; Dorward A; Hirasawa K
Sci Rep; 2020 Dec; 10(1):22124. PubMed ID: 33335181
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX.
Jonker JW; Musters S; Vlaming ML; Plösch T; Gooijert KE; Hillebrand MJ; Rosing H; Beijnen JH; Verkade HJ; Schinkel AH
Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2204-12. PubMed ID: 17314268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]